
The site is temporarily down due to maintenance. Sorry for the inconvenience.
The site is temporarily down due to maintenance. Sorry for the inconvenience.
Quality & Accuracy
Experience
The latest technologies
Speed &
Credibility
₾65.00
Apolipoproteins are components of quorum proteins (complex proteins) and are used to assess the risk of coronary heart disease.
Apolipoprotein A (APO-A) is the main component (90%) of high-density lipoproteins (HDL).
Apolipoprotein B (APO-B) is the main component of low-density lipoproteins (LDL) and regulates cholesterol synthesis and metabolism.
Of the apolipoproteins, APO-A1 and APO-B concentrations are the most stable and best reflect the relationship with the severity of cardiovascular diseases.
At present, there is an opinion that the APO-A1 level in the blood reflects the risk of coronary diseases better than HDL-cholesterol.
APO-A1/APO-B ratio is more sensitive than HDL/LDL or HDL/triglyceride ratio.
The purpose of the study is to assess the risk of developing coronary heart disease in patients:
Addition of the patient: The research should be done on an empty stomach, 12-14 hours after the last meal
Material for examination: Venous blood
APO-A1
| gender | norm(g/l) |
| woman | 1.08-2.25 |
| man | 1.04-2.02 |
APO-B
| gender | norm(g/l) |
| woman | 0.60-1.17 |
| man | 0.66-1.33 |
APO A-1/APO B ratio
| gender | APO0A1/APOB |
| woman | 0.94-1.33 |
| man | 0,80-1.33 |
| APO-A1 gain | APO-A1 reduction |
| Familial hyper-alpha-lipoproteinemia
· Pregnancy · Estrogen therapy · Alcohol consumption · Physical overload
|
· Diet
· smoke · Tangier disease · Familial hypo-alpha-lipoproteinemia · diabetes · Hemodialysis · Infections · Beta-lipoproteinemia · Apo AI-CIII deficiency Familial hypertriglyceridemia · Premature coronary heart disease · Hepatocellular damage · Nephrotic syndrome and kidney diseases
|
| APO-B increase | APO-B reduction |
| Hyperlipoproteinemia
· Apolipoprotein E deficiency Familial hyper-beta-apolipoproteinemia · Nephrotic syndrome · Pregnancy Biliary obstruction · Hemodialysis · smoke · diabetes · Hypothyroidism · Dysglobulinemia Porphyria · Cushing's syndrome |
Liver diseases
Hypo and abetalipoproteinemia · Reye's syndrome · Malabsorption/malnutrition · Hypothyroidism · APO C-II deficiency · Type I hyperlipidemia · Alpha-beta-lipoproteinemia · Infections · Overvoltage
|
drugs
Causes an increase in: carbamazepine, furosemide, oral contraceptives, phenobarbital, phenytoin, steroids, gemfibrozil, clofibrate
Lowering of the index causes: lovastatin
drugs
An increase in the rate is caused by: amiodarone, atenolol, cyclosporine, estrogens, furosemide, metoprolol, phenobarbital, radioactive iodine, androgens (anabolic steroids), chlorthialidone, gemfibrozil, isotretinoin, levonorgestrel, oral contraceptives, simvastatin, stanozolol,
Decreases: captopril, indomethacin, interferon, ketoconazole, neomycin, niacin, nifedipine, prazosin, prednisolone, tacrolimus, cholestyramine, colestipol, estrogens (post-menopausal), simvastatin, lovastatin, pravastatin, ketoconazole, neomycin, niacin
Very rarely, in gamopathy, especially Waldenström's disease, the test may give a false answer.
Other tests
Testing process
|
Purchase a test |
Submission of material |
|
Results Online |
Consult a doctor |